Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: A nationwide population-based follow-up study

Journal of Clinical Sleep Medicine

Volumn 11, Issue 5, 2015, Pages 543-551

  Chung, Kuo Hsuan ^a,b   Li, Chung Yi ^c,d   Kuo, Shu Yu ^e   Sithole, Trevor ^f   Liu, Wen Wei ^e   Chung, Min Huey ^e  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f Emkhuzweni Health Center   (Swaziland)

Author keywords

Anxiety disorder; Bipolar disorder; Depressive disorder; Insomnia; Schizophrenia; Sedative hypnotics; Somatoform disorder; Substance related disorder

Indexed keywords

ALPRAZOLAM; BROMAZEPAM; BROTIZOLAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; ESTAZOLAM; FLUDIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MEDAZEPAM; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADDICTION; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; DEPRESSION; DRUG HALF LIFE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MOOD DISORDER; PRESCRIPTION; SCHIZOPHRENIA; SOMATOFORM DISORDER; TREATMENT DURATION; COMORBIDITY; HEALTH SURVEY; INCIDENCE; MENTAL DISORDERS; RISK FACTOR; SLEEP INITIATION AND MAINTENANCE DISORDERS; TAIWAN;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; HYPNOTICS AND SEDATIVES; INCIDENCE; MALE; MENTAL DISORDERS; MIDDLE AGED; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TAIWAN;

EID: 84929312290     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.4700     Document Type: Article

References (48)

1. Kao CC, Huang CJ, Wang MY, Tsai PS. Insomnia: Prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population. Qual Life Res 2008; 17: 1073-80.
2. Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep 2000; 23: 41-7.
3. Li RHY, Wing YK, Ho SC, Fong SYY. Gender differences in insomnia - A study in the Hong Kong Chinese population. J Psychosom Res 2002; 53: 601-9.
4. Mai E, Buysse DJ. Insomnia: Prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin 2008; 3: 167-74.
5. Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 2002; 6: 97-111.
6. Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res 2002; 53: 593-600.
7. Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in Finland. J Sleep Res 2002; 11: 339-46.
8. Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav Sleep Med 2003; 1: 227-47.
9. Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm 2008; 65: 927-34.
10. Kim BS, Jeon HJ, Hong JP, et al. DSM-IV psychiatric comorbidity according to symptoms of insomnia: A nationwide sample of Korean adults. Soc Psychiatry Psychiatr Epidemiol 2012; 47: 2019-33.
11. Martinez-Gonzalez D, Obermeyer WH, Benca RM. Comorbidity of insomnia with medical and psychiatric disorders. Econ Neurosci 2001; 3: 48-57.
12. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007; 30: 873-80.
13. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989; 262: 1479-84.
14. Sarsour K, Morin CM, Foley K, Kalsekar A, Walsh JK. Association of insomnia severity and comorbid medical and psychiatric disorders in a health planbased sample: Insomnia severity and comorbidities. Sleep Med 2010; 11: 69-74.
15. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 2007; 30: 213-8.
16. Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011; 135: 10-9.
17. Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med 2007; 8: S15-S20.
18. Glidewell RN, Moorcroft WH, Lee-Chiong Jr T. Comorbid insomnia: Reciprocal relationships and medication management. Sleep Med Clin 2010; 5: 627-46.
19. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4: 487-504.
20. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: A matched cohort study. BMJ Open 2012; 2: E000850.
21. Kripke D. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 2007; 7: 42.
22. Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: Exploration of the direction of risk. J Psychiat Res 2006; 40: 700-8.
23. Okajima I, Komada Y, Nomura T, Nakashima K, Inoue Y. Insomnia as a risk for depression: A longitudinal epidemiologic study on a Japanese rural cohort. J Clin Psychiatry 2012; 73: 377-83.
24. Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients with schizophrenia: A meta-analysis. Schizophr Bull 2004; 30: 957-67.
25. Jackson A, Cavanagh J, Scott J. A systematic review of manic and depressive prodromes. J Affect Disord 2003; 74: 209-17.
26. Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry 2005; 27: 100-12.
27. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev 2010; 14: 35-46.
28. Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and long-term use of hypnotics: A population-based retrospective cohort study. PloS One 2012; 7: E49113.
29. Wang M-T, Su C-Y, Chan ALF, Lian P-W, Leu H-B, Hsu Y-J. Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: A population-based study. Br J Clin Pharmacol 2010; 70: 258-67.
30. Fang SY, Chen CY, Chang IS, Wu EC, Chang CM, Lin KM. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: A population-based study. Drug Alcohol Depen 2009; 104: 140-6.
31. Nomura K, Nakao M, Sato M, Yano E. Regular prescriptions for benzodiazepines: A cross-sectional study of outpatients at a university hospital. Intern Med 2006; 45: 1279-83.
32. Liu CY HY, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. Int J Healthc Manag 2006; 4: 22.
33. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.
34. Bobo WV, Reilly-Harrington NA, Ketter TA, et al. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: Results from the Bipolar CHOICE trial. J Affect Disord 2014; 161: 30-5.
35. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: Therapeutic implications. Am J Psychiatry 2008; 165: 830-43.
36. Wehr TA, Sack DA, Rosenthal NE. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987; 144: 201-4.
37. Yang C, Winkelman JW. Clinical significance of sleep EEG abnormalities in chronic schizophrenia. Schizophren Res 2006; 82: 251-60.
38. Monti JM, Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 2004; 8: 133-48.
39. Kitajima R, Miyamoto S, Tenjin T, et al. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 300-6.
40. Zohar D, Tzischinsky O, Epstein R, Lavie P. The effects of sleep loss on medical residents' emotional reactions to work events: A cognitive-energy model. Sleep 2005; 28: 47-54.
41. Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Med Rev 2010; 14: 19-31.
42. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M. Somatoform disorders: Time for a new approach in DSM-V. Am J Psychiatry 2005; 162: 847-55.
43. Zhang J, Lam SP, Li SX, et al. Insomnia, sleep quality, pain, and somatic symptoms: Sex differences and shared genetic components. Pain 2012; 153: 666-73.
44. Richardson GS. Managing insomnia in the primary care setting: Raising the issues. Sleep 2000; 23: S9-12; discussion S3-5.
45. Konopka A, Pelka-Wysiecka J, Grzywacz A, Samochowiec J. Psychosocial characteristics of benzodiazepine addicts compared to not addicted benzodiazepine users. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40: 229-35.
46. Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2005; 18: 249-55.
47. Albrecht JS, Gruber-Baldini AL, Hirshon JM et al. Depressive Symptoms and Hospital Readmission in Older Adults. J Am Geriatr Soc 2014; 62: 495-9.
48. Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 2006; 7: 312-8.